1. Home
  2. Aromatase inhibitor
  Subject:

Aromatase inhibitor   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Breast cancer  10 times
Hormone  7 times
Estrogen receptor  6 times
Enzyme inhibitor  5 times
Progression-free survival  4 times
Neu!  3 times
Tamoxifen  2 times
Stomatitis  2 times
Mechanistic target of rapamycin  2 times
Lymph node  2 times
Hypothalamus  2 times
Growth factor  2 times
Gene  2 times
Estrogen  2 times
Endocrine system  2 times
Biopsy  2 times
Topical medication  1 time
Testosterone  1 time
TNBC  1 time
Statistical hypothesis testing  1 time
Sirolimus  1 time
Sex steroid  1 time
Sentinel lymph node  1 time
Sarcoma  1 time
Radiation therapy  1 time
Protein  1 time
Prenatal development  1 time
Precision medicine  1 time
Placebo  1 time
Pituitary gland  1 time
Ovary  1 time
Obesity  1 time
Neutropenia  1 time
Neoplasm  1 time
Neoadjuvant therapy  1 time
Mouse  1 time
Monoclonal antibody  1 time
Microarray  1 time
Metastasis  1 time
Messenger RNA  1 time
Japan  1 time
Invasive carcinoma of no special type  1 time
Interquartile range  1 time
International law  1 time
Insulin-like growth factor 1 receptor  1 time
Insulin  1 time
Immunoprecipitation  1 time
Hysterectomy  1 time
Hypovolemia  1 time
Hyperprolactinaemia  1 time
Hyperglycemia  1 time
Histology  1 time
Genome-wide association study  1 time
Gene ontology  1 time
G1 phase  1 time
Everolimus  1 time
Estrone  1 time
Estradiol  1 time
Epigenetics  1 time
Eocene  1 time
Cyclin-dependent kinase 4  1 time
Cyclin-dependent kinase  1 time
Chromosome  1 time
Chemotherapy  1 time
Cell cycle  1 time
Carcinoma  1 time
Body mass index  1 time
Blood plasma  1 time
Artificial intelligence  1 time
Arthralgia  1 time
Aromatase  1 time
Anorexia nervosa  1 time
Androstenedione  1 time
Androgen  1 time
Allele  1 time
Agonist  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

2. Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer

3. Ribociclib: First Global Approval

4. A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer

5. Sex differences in microRNA-mRNA networks: examination of novel epigenetic programming mechanisms in the sexually dimorphic neonatal hypothalamus

6. Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats

7. A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

8. Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report

9. Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population

10. SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway

11. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study)

12. Primary ectopic breast cancer of the vulva, treated with local excision of the vulva and sentinel lymph node biopsy: a case report

13. Extended Endocrine Therapy: Is 5 Years Enough?


Questions?

Drop us a message.